145508-52-7

Upstream product

• 98906-30-0 (±)-2,3,6-tri-O-benzyl-myo-inositol 
• 114218-19-8 1-O-Allyl-2,3,6-tri-O-benzyl-4,5-O-isopropylidene-myo-inositol 
• 115072-72-5 (3aR,4S,5R,6R,7S,7aR)-4,5,7-Tris-benzyloxy-2,2-dimethyl-6-[((E)-propenyl)oxy]-hexahydro-benzo[1,3]dioxole 
• 114218-23-4 (+/-)-1-O-allyl-3,6-di-O-benzyl-4,5-O-isopropylidene-myo-inositol 
• 115072-72-5 2,3,6-tri-O-benzyl-4,5-isopropylidene-1-O-(prop-1-enyl)-myo-inositol 

Downstream Products

• 132151-61-2 myo-Inositol 1,4,5-trissulphonamide 

Relevant academic research and scientific papers

Synthesis of analogues of myo-inositol 1,4,5-trisphosphate that contain sulfonamide, sulfate, methylphosphonate, and carboxymethyl groups

The syntheses are described of four isosteric racemic myo-inositol 1,4,5-trisphosphate (1) analogues with the phosphate groups replaced by sulfonamide (2), sulfate (3), methylphosphonate (4), and carboxymethyl (5). None of these compounds had any affinity

Synthesis of 1,4,5-trissulphated and 1,4,5-trissulphamoylated myo-inositols: Isosteric myo-inositol 1,4,5-trisphosphate analogues

Synthesis of the myo-inositol 1,4,5-trisphosphate isosteric analogues (rac.) 1,4,5-trissulphate and (rac.) 1,4,5-trissulphonamido was accomplished from 1,2,4-tri-O-benzyl myo-inositol.